Nilotinib
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Nilotinib is used to treat gastrointestinal stromal tumors, leukemia, myeloid, accelerated phase and leukemia, myeloid, chronic-phase, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 29, 2026.
Nilotinib is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $94.15 to $94.15 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$94.15 – $94.15
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing NILOTINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TASIGNA 200 MG CAPSULE | $94.1452 per EA | — |
TASIGNA 200 MG CAPSULE | $94.1452 per EA | — |
Frequently Asked Questions
What is Nilotinib used to treat?
Nilotinib is used to treat gastrointestinal stromal tumors, leukemia, myeloid, accelerated phase and leukemia, myeloid, chronic-phase, per the National Library of Medicine's MED-RT classification.
How many Nilotinib products are on the market?
The Nilotinib drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Nilotinib?
NADAC reference prices for Nilotinib range from $94.1452 to $94.1452 per EA.
Which manufacturers make Nilotinib?
1 manufacturer lists Nilotinib in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (2).